The upregulation of OPN in response to diabetic conditions, particularly notable in HFD and STZ-treated groups, highlights its role in mediating inflammatory processes on the ocular surface, suggesting OPN’s involvement in the pathophysiology of diabetes-related ocular complications. The gene discussed is SPP1; the disease is diabetes mellitus.